Exprivia SpA
MIL:XPR
Intrinsic Value
Exprivia SpA engages in the provision of process consultancy, technology services and Information Technology solutions. [ Read More ]
The intrinsic value of one XPR stock under the Base Case scenario is hidden EUR. Compared to the current market price of 1.65 EUR, Exprivia SpA is hidden .
Valuation Backtest
Exprivia SpA
Run backtest to discover the historical profit from buying and selling XPR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Exprivia SpA
Current Assets | 126m |
Cash & Short-Term Investments | 24.1m |
Receivables | 69.4m |
Other Current Assets | 32.5m |
Non-Current Assets | 97.4m |
Long-Term Investments | 1.2m |
PP&E | 17.4m |
Intangibles | 76.4m |
Other Non-Current Assets | 2.3m |
Current Liabilities | 105.5m |
Accounts Payable | 33.7m |
Accrued Liabilities | 29.4m |
Other Current Liabilities | 42.3m |
Non-Current Liabilities | 23m |
Long-Term Debt | 14.5m |
Other Non-Current Liabilities | 8.5m |
Earnings Waterfall
Exprivia SpA
Revenue
|
195m
EUR
|
Cost of Revenue
|
-10.7m
EUR
|
Gross Profit
|
184.3m
EUR
|
Operating Expenses
|
-162.9m
EUR
|
Operating Income
|
21.4m
EUR
|
Other Expenses
|
-8.2m
EUR
|
Net Income
|
13.1m
EUR
|
Free Cash Flow Analysis
Exprivia SpA
XPR Profitability Score
Profitability Due Diligence
Exprivia SpA's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Exprivia SpA's profitability score is hidden . The higher the profitability score, the more profitable the company is.
XPR Solvency Score
Solvency Due Diligence
Exprivia SpA's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Exprivia SpA's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XPR Price Targets Summary
Exprivia SpA
According to Wall Street analysts, the average 1-year price target for XPR is 1.7 EUR .
Shareholder Return
XPR Price
Exprivia SpA
Average Annual Return | 29.47% |
Standard Deviation of Annual Returns | 100.45% |
Max Drawdown | -55% |
Market Capitalization | 76.2m EUR |
Shares Outstanding | 46 906 200 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Exprivia SpA engages in the provision of process consultancy, technology services and Information Technology solutions. The company is headquartered in Molfetta, Bari. The firm is active in the design, development and integration of IT systems; enterprise application integration; infrastructure management services; business process outsourcing, and information technology security solutions. The firm offers its IT products and services to various market, such as healthcare sector and local entities; banks and financial institutions; industry and media companies; oil, gas and telecommunication sector; space and defence; public administration, and transport and utilities industry. The firm has a number of subsidiaries and affiliates, including Exprivia Projects SpA, Italtel, Exprivia Solutions, Devoteam auSystem SpA, Exprivia Asia Ltd, ACS SpA and ProSAP SL, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one XPR stock under the Base Case scenario is hidden EUR.
Compared to the current market price of 1.65 EUR, Exprivia SpA is hidden .